Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Augmntr, Inc in June, 2018 for $148,311.0 USD from the U.S. Department of Defense and United States Air Force. | SBIR | FA9101-18-P-0019 | Phase I | 148,311 | June 25, 2018 | |||||||
A SBIR Phase II contract was awarded to Augmntr, Inc in August, 2019 for $749,668.0 USD from the U.S. Department of Defense and United States Air Force. | SBIR | FA9101-19-C-0055 | Phase II | 749,668 | August 7, 2019 | |||||||
A STTR Phase I contract was awarded to Augmntr, Inc in June, 2022 for $172,785.0 USD from the U.S. Department of Defense and United States Army. | STTR | W56HZV-22-C-0020 | Phase I | 172,785 | June 29, 2022 | |||||||
A SBIR Phase II contract was awarded to Augmntr, Inc in September, 2020 for $1,095,599.0 USD from the U.S. Department of Defense and Defense Health Agency. | SBIR | W81XWH20C0089 | Phase II | 1,095,599 | September 28, 2020 | |||||||
A SBIR Phase I contract was awarded to Augmntr, Inc in May, 2020 for $140,000.0 USD from the U.S. Department of Defense and United States Navy. | SBIR | N68335-20-C-0608 | Phase I | 140,000 | May 29, 2020 | |||||||
A SBIR Phase I contract was awarded to Augmntr, Inc in November, 2020 for $139,283.0 USD from the U.S. Department of Defense and United States Navy. | SBIR | M67854-21-P-6603 | Phase I | 139,283 | November 19, 2020 | |||||||
A SBIR Phase I contract was awarded to Augmntr, Inc in July, 2019 for $162,199.0 USD from the U.S. Department of Defense and Defense Health Agency. | SBIR | W81XWH19C0131 | Phase I | 162,199 | July 8, 2019 | |||||||
A SBIR Phase I contract was awarded to Augmntr, Inc in November, 2021 for $167,480.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense. | SBIR | W911-NF-22-P-0001 | Phase I | 167,480 | November 5, 2021 | |||||||
A SBIR Phase II contract was awarded to Augmntr, Inc in March, 2023 for $597,486.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense. | SBIR | W911-NF-23-C-0007 | Phase II | 597,486 | March 27, 2023 | |||||||
A SBIR Phase II contract was awarded to Augmntr, Inc in September, 2023 for $1,299,972.0 USD from the U.S. Department of Defense and Defense Health Agency. | SBIR | HT9425-23-C-0070 | Phase II | 1,299,972 | September 22, 2023 |